FDA Inspection 1114618 — Barry J. Byrne, M.D., Ph.D.
The FDA completed an inspection of Barry J. Byrne, M.D., Ph.D. on December 12, 2019 in Gainesville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 12, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Gainesville, FL (United States)
Additional Details
Clinical Investigator (CI)